Apexigen(美國(guó))

Apexigen

美國(guó)Apexigen www.apexigen.comApexigen是一家位于美國(guó)灣區(qū)的專注于治療性抗體的研發(fā)和市場(chǎng)化的生物制藥公司，廣泛與國(guó)內(nèi)外的生物制藥及生物技術(shù)公司如美國(guó)強(qiáng)聲、諾華制藥、先聲藥業(yè)，三生制藥等開(kāi)展合作，擁有一流的抗體技術(shù)平臺(tái)及豐富的產(chǎn)品線，包括用于治療癌癥及炎癥的7個(gè)人源化兔單克隆抗體等。Apexigenisabiopharmaceutcalcompanyfocusedond iscoveringanddevelopingbest-in-classdrugsfromitsproprietarymonoclonalantibodytechnologyplatforms.Monoclonalantibodiesspecificallytargetcellsorproteinsthatareessentialcomponentsofdiseasesprocessesandactivatethebody’simmunesystemtoremoveorneutralizeproteinsandcellsthatcauseorperpetuatedisease.Apexigen’stechnologytakesadvantageoftheextensivediversityinantibodyspecificitythatisproducedbytherabbit’simmunesystem.Fromthisvariety,veryhighaffinityantibodiescanbeidentifiedwhichhaveveryexactingspecificityanduniqueepitopesfordiseasetargets.Suchantibodiesmayhaveincreasedpotency,efficacyanddiseasemodifyingability.Apexigen’spropr